HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvana Del Vecchio Selected Research

integrin beta5

8/2009Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvana Del Vecchio Research Topics

Disease

30Neoplasms (Cancer)
10/2022 - 03/2004
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 03/2012
7Breast Neoplasms (Breast Cancer)
08/2020 - 06/2002
6Multiple Myeloma
04/2015 - 04/2004
5Neoplasm Metastasis (Metastasis)
08/2020 - 11/2005
3Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2022 - 03/2004
2Carcinoma (Carcinomatosis)
08/2020 - 06/2003
2Thyroid Neoplasms (Thyroid Cancer)
04/2016 - 12/2013
1Hodgkin Disease (Hodgkin's Disease)
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Osteomalacia
01/2022
1Hypophosphatemia
01/2022
1Fibrosarcoma
08/2020
1Melanoma (Melanoma, Malignant)
06/2020
1Brain Neoplasms (Brain Tumor)
06/2020
1Lymphoma (Lymphomas)
06/2020
1Leukemia
06/2019
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2019
1Hypoxia (Hypoxemia)
01/2019
1Solitary Pulmonary Nodule
10/2018
1Graves Disease (Basedow Disease)
12/2013
1Adenoma (Adenomas)
12/2013
1Thymoma (Thymic Carcinoma)
05/2013
1Colorectal Neoplasms (Colorectal Cancer)
01/2013
1Lung Neoplasms (Lung Cancer)
08/2008
1Osteonecrosis (Kienbock's Disease)
06/2007

Drug/Important Bio-Agent (IBA)

9Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2019 - 02/2008
6Tyrosine Kinase InhibitorsIBA
08/2021 - 08/2008
5Glucose (Dextrose)FDA LinkGeneric
08/2021 - 11/2015
5IntegrinsIBA
08/2020 - 06/2006
5Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 08/2008
4Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2016
4Peptides (Polypeptides)IBA
08/2020 - 03/2004
3Biological ProductsIBA
10/2022 - 06/2004
3Proteins (Proteins, Gene)FDA Link
06/2020 - 04/2004
3CrizotinibIBA
01/2018 - 09/2014
3ErbB Receptors (EGF Receptor)IBA
01/2013 - 08/2008
3Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
08/2008 - 01/2005
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2004 - 06/2002
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
10/2022 - 01/2022
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2020 - 11/2005
2Monoclonal AntibodiesIBA
06/2020 - 01/2013
2Pharmaceutical PreparationsIBA
03/2017 - 08/2008
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2005
2Mitochondrial Proteins (Mitochondrial Protein)IBA
12/2016 - 11/2015
2WZ4002IBA
12/2016 - 03/2012
2Octreotide (Sandostatin)FDA LinkGeneric
04/2016 - 05/2013
2indium-111-octreotideIBA
04/2016 - 05/2013
2CationsIBA
08/2008 - 06/2004
2Apoptosis Regulatory ProteinsIBA
04/2004 - 06/2003
1Ga(III)-DOTATOCIBA
10/2022
1burosumabIBA
01/2022
1Fibroblast Growth Factor-23IBA
01/2022
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022
1Phosphates (Orthophosphate)IBA
01/2022
1liposomal doxorubicin (Doxil)FDA Link
01/2022
1CollagenIBA
08/2020
1NivolumabIBA
06/2020
1IpilimumabIBA
06/2020
1Immune Checkpoint InhibitorsIBA
06/2020
1Imatinib Mesylate (Gleevec)FDA Link
06/2019
1EnzymesIBA
06/2019
1alovudineIBA
01/2018
1Inositol (Myoinositol)IBA
01/2018
1Serine (L-Serine)FDA Link
01/2018
1Drug CombinationsIBA
01/2018
1Histones (Histone)IBA
01/2017
1Cyclin D1IBA
12/2016
1Phosphotransferases (Kinase)IBA
12/2016
1Fluorine-18IBA
04/2016
1Indium-111IBA
04/2016
1Lactic Acid (Lactate)FDA LinkGeneric
11/2015
1Gadolinium DTPA (Magnevist)FDA Link
01/2014
1Sphingosine-1-Phosphate ReceptorsIBA
01/2013
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2013
1Cetuximab (Erbitux)FDA Link
01/2013
1sphingosine kinaseIBA
01/2013
1CL 387785IBA
03/2012
1navitoclaxIBA
03/2012
1Amino AcidsFDA Link
08/2009
1integrin beta5IBA
08/2009
1Gefitinib (Iressa)FDA Link
08/2008
1Diphosphonates (Bisphosphonates)IBA
06/2007
1Urokinase Plasminogen Activator ReceptorsIBA
11/2005
1Complementary DNA (cDNA)IBA
11/2005
1Therapeutic UsesIBA
11/2005
1Indicators and Reagents (Reagents)IBA
11/2005
1RadiopharmaceuticalsIBA
03/2004
1Cholecystokinin (Pancreozymin)IBA
03/2004

Therapy/Procedure

11Therapeutics
10/2022 - 03/2004
5Aftercare (After-Treatment)
06/2020 - 08/2008
3Immunotherapy
06/2020 - 08/2017
1Palliative Care (Palliative Therapy)
06/2020
1Radiotherapy
01/2019
1Drug Therapy (Chemotherapy)
03/2017
1Thyroidectomy
12/2013